Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
JCI Insight ; 6(3)2021 02 08.
Artículo en Inglés | MEDLINE | ID: mdl-33351789

RESUMEN

Paucity of the glucose transporter-1 (Glut1) protein resulting from haploinsufficiency of the SLC2A1 gene arrests cerebral angiogenesis and disrupts brain function to cause Glut1 deficiency syndrome (Glut1 DS). Restoring Glut1 to Glut1 DS model mice prevents disease, but the precise cellular sites of action of the transporter, its temporal requirements, and the mechanisms linking scarcity of the protein to brain cell dysfunction remain poorly understood. Here, we show that Glut1 functions in a cell-autonomous manner in the cerebral microvasculature to affect endothelial tip cells and, thus, brain angiogenesis. Moreover, brain endothelial cell-specific Glut1 depletion not only triggers a severe neuroinflammatory response in the Glut1 DS brain, but also reduces levels of brain-derived neurotrophic factor (BDNF) and causes overt disease. Reduced BDNF correlated with fewer neurons in the Glut1 DS brain. Controlled depletion of the protein demonstrated that brain pathology and disease severity was greatest when Glut1 scarcity was induced neonatally, during brain angiogenesis. Reducing Glut1 at later stages had mild or little effect. Our results suggest that targeting brain endothelial cells during early development is important to ensure proper brain angiogenesis, prevent neuroinflammation, maintain BDNF levels, and preserve neuron numbers. This requirement will be essential for any disease-modifying therapeutic strategy for Glut1 DS.


Asunto(s)
Errores Innatos del Metabolismo de los Carbohidratos/metabolismo , Transportador de Glucosa de Tipo 1/deficiencia , Transportador de Glucosa de Tipo 1/metabolismo , Proteínas de Transporte de Monosacáridos/deficiencia , Animales , Animales Recién Nacidos , Encéfalo/irrigación sanguínea , Encéfalo/metabolismo , Encéfalo/patología , Factor Neurotrófico Derivado del Encéfalo/deficiencia , Factor Neurotrófico Derivado del Encéfalo/metabolismo , Errores Innatos del Metabolismo de los Carbohidratos/genética , Errores Innatos del Metabolismo de los Carbohidratos/patología , Modelos Animales de Enfermedad , Células Endoteliales/metabolismo , Células Endoteliales/patología , Femenino , Técnicas de Silenciamiento del Gen , Transportador de Glucosa de Tipo 1/genética , Haploinsuficiencia , Masculino , Ratones , Ratones de la Cepa 129 , Ratones Noqueados , Proteínas de Transporte de Monosacáridos/genética , Proteínas de Transporte de Monosacáridos/metabolismo , Neovascularización Fisiológica/genética , Neuronas/metabolismo , Neuronas/patología , Fenotipo
2.
Neuron ; 83(3): 630-44, 2014 Aug 06.
Artículo en Inglés | MEDLINE | ID: mdl-25043419

RESUMEN

In Drosophila, the four inner photoreceptor neurons exhibit overlapping but distinct spectral sensitivities and mediate behaviors that reflect spectral preference. We developed a genetic strategy, Tango-Trace, that has permitted the identification of the connections of the four chromatic photoreceptors. Each of the four stochastically distributed chromatic photoreceptor subtypes make distinct connections in the medulla with four different TmY cells. Moreover, each class of TmY cells forms a retinotopic map in both the medulla and the lobula complex, generating four overlapping topographic maps that could carry different color information. Thus, the four inner photoreceptors transmit spectral information through distinct channels that may converge in both the medulla and lobula complex. These projections could provide an anatomic basis for color vision and may relay information about color to motion sensitive areas. Moreover, the Tango-Trace strategy we used may be applied more generally to identify neural circuits in the fly brain.


Asunto(s)
Translocador Nuclear del Receptor de Aril Hidrocarburo/metabolismo , Canales de Cloruro/metabolismo , Visión de Colores/fisiología , Proteínas de Drosophila/metabolismo , Drosophila melanogaster/metabolismo , Bulbo Raquídeo/fisiología , Movimiento (Física) , Células Fotorreceptoras/metabolismo , Receptores Histamínicos H2/metabolismo , Proteínas Recombinantes de Fusión/metabolismo , Factores de Transcripción/metabolismo , Animales , Red Nerviosa/fisiología , Neuronas/metabolismo , Estimulación Luminosa/métodos
3.
Cell ; 148(3): 583-95, 2012 Feb 03.
Artículo en Inglés | MEDLINE | ID: mdl-22304923

RESUMEN

Behavior cannot be predicted from a "connectome" because the brain contains a chemical "map" of neuromodulation superimposed upon its synaptic connectivity map. Neuromodulation changes how neural circuits process information in different states, such as hunger or arousal. Here we describe a genetically based method to map, in an unbiased and brain-wide manner, sites of neuromodulation under different conditions in the Drosophila brain. This method, and genetic perturbations, reveal that the well-known effect of hunger to enhance behavioral sensitivity to sugar is mediated, at least in part, by the release of dopamine onto primary gustatory sensory neurons, which enhances sugar-evoked calcium influx. These data reinforce the concept that sensory neurons constitute an important locus for state-dependent gain control of behavior and introduce a methodology that can be extended to other neuromodulators and model organisms.


Asunto(s)
Dopamina/metabolismo , Drosophila melanogaster/fisiología , Neurotransmisores/metabolismo , Transducción de Señal , Animales , Regulación del Apetito , Arrestina/metabolismo , Encéfalo/fisiología , Mapeo Encefálico/métodos , Conducta Alimentaria , Femenino , Receptores Dopaminérgicos/metabolismo , Células Receptoras Sensoriales/metabolismo
4.
Proc Natl Acad Sci U S A ; 103(29): 11051-6, 2006 Jul 18.
Artículo en Inglés | MEDLINE | ID: mdl-16832049

RESUMEN

Several neurodegenerative diseases are associated with the toxicity of misfolded proteins. This toxicity must arise from a combination of the amino acid sequences of the misfolded proteins and their interactions with other factors in their environment. A particularly compelling example of how profoundly these intramolecular and intermolecular factors can modulate the toxicity of a misfolded protein is provided by the polyglutamine (polyQ) diseases. All of these disorders are caused by glutamine expansions in proteins that are broadly expressed, yet the nature of the proteins that harbor the glutamine expansions and the particular pathologies they produce are very different. We find, using a yeast model, that amino acid sequences that modulate polyQ toxicity in cis can also do so in trans. Furthermore, the prion conformation of the yeast protein Rnq1 and the level of expression of a suite of other glutamine-rich proteins profoundly affect polyQ toxicity. They can convert polyQ expansion proteins from toxic to benign and vice versa. Our work presents a paradigm for how a complex, dynamic interplay between intramolecular features of polyQ proteins and intermolecular factors in the cellular environment might determine the unique pathobiologies of polyQ expansion proteins.


Asunto(s)
Proteínas del Tejido Nervioso/genética , Proteínas Nucleares/genética , Péptidos/metabolismo , Péptidos/toxicidad , Priones/metabolismo , Proteínas de Saccharomyces cerevisiae/metabolismo , Saccharomyces cerevisiae/efectos de los fármacos , Saccharomyces cerevisiae/metabolismo , ADN Intergénico/genética , Exones/genética , Humanos , Proteína Huntingtina , Péptidos/genética , Priones/genética , Unión Proteica , Proteínas de Saccharomyces cerevisiae/genética
5.
Proc Natl Acad Sci U S A ; 103(29): 11045-50, 2006 Jul 18.
Artículo en Inglés | MEDLINE | ID: mdl-16832050

RESUMEN

Protein misfolding is the molecular basis for several human diseases. How the primary amino acid sequence triggers misfolding and determines the benign or toxic character of the misfolded protein remains largely obscure. Among proteins that misfold, polyglutamine (polyQ) expansion proteins provide an interesting case: Each causes a distinct neurodegenerative disease that selectively affects different neurons. However, all are broadly expressed and most become toxic when the glutamine expansion exceeds approximately 39 glutamine residues. The disease-causing polyQ expansion proteins differ profoundly in the amino acids flanking the polyQ region. We therefore hypothesized that these flanking sequences influence the specific toxic character of each polyQ expansion protein. Using a yeast model, we find that sequences flanking the polyQ region of human huntingtin exon I can convert a benign protein to a toxic species and vice versa. Further, we observe that flanking sequences can direct polyQ misfolding to at least two morphologically distinct types of polyQ aggregates. Very tight aggregates always are benign, whereas amorphous aggregates can be toxic. We thereby establish a previously undescribed systematic characterization of the influence of flanking amino acid sequences on polyQ toxicity.


Asunto(s)
ADN Intergénico/genética , Péptidos/genética , Péptidos/toxicidad , Saccharomyces cerevisiae/efectos de los fármacos , Saccharomyces cerevisiae/genética , Forma de la Célula , Exones/genética , Genes Reporteros/genética , Humanos , Proteína Huntingtina , Proteínas del Tejido Nervioso/genética , Proteínas Nucleares/genética , Péptidos/metabolismo , Saccharomyces cerevisiae/citología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...